Unleashing the immune system’s ‘STING’ against cancer
Scientists at Scripps Research have discovered a molecule that can activate a natural immune-boosting protein called STING.
Read MoreCancer
Fighting cancer with rejection-resistant, ‘off-the-shelf’ therapeutic T cells
Personalised cancer treatments are no longer just options of the future. In the past few years, researchers have made significant […]
Read MoreA metabolic enzyme as a potential new target for cancer immune therapies
The metabolic enzyme IL4I1 (Interleukin-4-Induced-1) promotes the spread of tumour cells and suppresses the immune system.
Read MoreAntibiotic overuse reduces bladder cancer survival rates
The over prescribing of antibiotics is reducing survival rates in patients with urothelial carcinoma and it needs to be stopped to avoid the serious risk posed by resistant bacterial infections, according to a new medical study.
Read MoreCOVID-19 has major impact on psycho-social care of cancer patients
Psychosocial needs of people affected by cancer are not being adequately met due to the disruption in services caused by COVID-19, a report in the journal Psycho-Oncology reports.
Read MoreNew blood test can confirm prostate cancer – and what stage it is at
A new blood test developed by scientists and clinicians is able to detect the presence of prostate cancer and confirm how advanced it is.
Read MoreStudy finds global trends in women’s breast cancer show cause for concern
Breast cancer rates among women globally are on the rise, but new research is uncovering trends related to age and where you live that could help target prevention measures to improve the situation.
Read MoreDiscovery of key protein behind cancer relapse and progression can lead to new therapies
Cancer cases have been rising over the years and according to the statistics, the number of people living with cancer […]
Read MoreEngineered immune cells recognise, attack human and mouse solid-tumour cancer cells
In a new study, researchers report that they have dramatically broadened the potential targets of CAR-T therapy – their engineered T-cells attack a variety of solid-tumour cancer cells from humans and mice.
Read MoreArtificial intelligence can categorise cancer risk of lung nodules
A study published in American Journal of Respiratory and Critical Care Medicine indicates that an artificial intelligence strategy can correctly assess and categorise these indeterminate pulmonary nodules (IPNs).
Read More